Founders Fund

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across multiple stages, from seed to late-stage. It pursues transformative technologies and follows a founder-friendly investment approach that provides substantial support with minimal interference. The firm invests in ventures solving difficult problems across sectors such as aerospace and transportation, artificial intelligence, advanced computing, energy, healthcare, biotechnology, cybersecurity, fintech, consumer internet, software, robotics, and related technology fields. It has backed notable companies early, including SpaceX, Palantir, and Facebook, reflecting a history of partnering with ambitious founders to scale breakthrough technologies.

Delian Asparouhov

Partner

Jennifer Campbell

Partner

Bridget Harris

Associate

Joey Krug

Partner

Sean Liu

Partner

Jeffrey Lonsdale

Managing Director, Asia

John Luttig

Partner

Amin Mirzadegan

Partner

Scott Nolan

Partner

Luke Nosek

Managing Partner

Stephen Oskoui

Venture Partner

Ryan Petersen

Partner

Keith Rabois

Partner

Neil Ruthven

CFO

Napoleon Ta

Partner

Matias Van Thienen

Partner

Past deals in Image Recognition

HeartLab

Seed Round in 2021
HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

Scale AI

Series E in 2021
Scale AI develops a platform that provides training and validation data for artificial intelligence applications. Its products include advanced annotation tools for images, videos, text, documents, and 3D sensor data, serving sectors such as autonomous vehicles, retail, conversational AI, robotics, AR/VR, and document processing.

HeartLab

Seed Round in 2020
HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

AI Foundation

Series B in 2020
AI Foundation develops AI-based software solutions to detect malicious content online. Its flagship tool, Reality Defender, scans media for signs of alteration or artificial generation. The company also enables content creators to establish honest AI watermarks. Serving academia, businesses, and governments, AI Foundation has partnerships with notable entities like Marvel filmmakers Joe and Anthony Russo, Google, Microsoft, Twitter, and universities. Founded in 2017, it is headquartered in Las Vegas, Nevada.

Formatech

Seed Round in 2020
Forma is building photorealistic avatars that are a dynamic and deeply personal form for people’s online identity. We believe that as our online lives grow in importance, people look for more authenticity and relatability - and for everybody on the planet there is nothing more familiar than an image of themselves. Through Forma’s computer vision and graphics technology, users can create a flexible visual identity from a single photo of themselves, instantly and photorealistically. ​Today they can try on any outfit whether just for fun or before buying on e-commerce, and soon they will be able star in a movie, video game, TV show, YouTube clip, billboard ad, VR/AR, etc. The company was founded in late 2017, early in the commercialization of the recent breakthroughs in deep learning. We’ve raised seed funding from top VCs and angels and are SF-based by the Caltrain station.

Scale AI

Series C in 2019
Scale AI develops a platform that provides training and validation data for artificial intelligence applications. Its products include advanced annotation tools for images, videos, text, documents, and 3D sensor data, serving sectors such as autonomous vehicles, retail, conversational AI, robotics, AR/VR, and document processing.

AI Foundation

Series A in 2018
AI Foundation develops AI-based software solutions to detect malicious content online. Its flagship tool, Reality Defender, scans media for signs of alteration or artificial generation. The company also enables content creators to establish honest AI watermarks. Serving academia, businesses, and governments, AI Foundation has partnerships with notable entities like Marvel filmmakers Joe and Anthony Russo, Google, Microsoft, Twitter, and universities. Founded in 2017, it is headquartered in Las Vegas, Nevada.

Morphin

Venture Round in 2018
Morphin is a technology company that specializes in creating personalized GIFs and avatars for users. Its innovative image-mapping application allows individuals to generate custom three-dimensional avatars that can be utilized across various platforms, including virtual reality and augmented reality applications as well as video games. By focusing on user customization, Morphin enables clients to express themselves in unique ways through their digital representations, facilitating a more engaging and personalized experience in the virtual realm.

HeartLab

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

HeartLab

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.